Search for: "MERCK/SCHERING-PLOUGH PHARMACEUTICALS"
Results 41 - 60
of 72
Sorted by Relevance
|
Sort by Date
15 Feb 2012, 7:42 am
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Sep 2011, 12:08 pm
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
13 Oct 2008, 9:59 pm
Last winter, Merck and Schering-Plough were criticized for delaying the release of a study on their best-selling cholesterol medication Vytorin that showed the drug did not slow the growth of plaque in arteries. [read post]
5 Aug 2009, 12:50 pm
· Merck/Schering-Plough’s one-minute ad for the cholesterol-lowering drug Vytorin is a standard example: it repeats the drug’s benefits over and over, but squeezes in risk information only once and just after the halfway mark. [read post]
23 May 2011, 1:54 pm
Court of Appeals for the Eleventh Circuit upheld in Schering-Plough Corp. v. [read post]
3 Nov 2011, 10:44 am
MANUFACTURERS: Organon Pharmaceuticals USA Inc., Organon USA Inc., Organon International Inc., Schering Plough Corp., and Akzo Nobel NV. [read post]
28 Mar 2011, 1:57 pm
Form 10-K Annual Report For the Fiscal Year Ended December 31, 2010, which was filed with the Securities and Exchange Commission on February 28, 2011: Beginning in May 2007, a number of complaints were filed in various jurisdictions asserting claims against the Company’s subsidiaries Organon USA, Inc., Organon Pharmaceuticals USA, Inc., Organon International (collectively, “Organon”), and Schering-Plough arising from Organon’s marketing and sale of… [read post]
20 Mar 2018, 7:27 am
The employee, a former sales representative for three firms (Millennium Pharmaceuticals, Schering-Plough, and Merck), filed the original action in 2009, alleging violations of state law and the FCA for promoting off-label uses of Integrilin, and paying kickbacks to physicians for prescribing Integrilin and Avelox. [read post]
31 Dec 2009, 7:19 am
’s proposed $68 billion acquisition of Wyeth, and Schering-Plough Corporation was permitted to proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
24 Oct 2012, 10:02 am
Since that time, first, Organon was acquired by Schering-Plough and, later, Merck took over Schering-Plough and Organon. [read post]
6 Sep 2007, 12:08 pm
Schering-Plough Corp., 367 N.J. [read post]
29 Aug 2012, 10:09 pm
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants, including Upsher-Smith Laboratories (“Upsher-Smith”). [read post]
20 Oct 2011, 5:36 am
And to our friends at Aetna: You should consider sending a similar drug injury subrogation letter to women who have used the NuvaRing birth control product from Merck, Schering-Plough, and Organon. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects Drug Injury Case Evaluation - Free & Confidential [read post]
25 Jun 2015, 5:00 am
See In re Schering-Plough Corp. [read post]
9 Nov 2009, 6:01 am
., pharmaceutical companies have been pleading guilty to criminal charges or paying penalties in civil cases when the U.S. [read post]
5 Mar 2014, 2:46 pm
Schering-Plough Corp., California Supreme Court – existence of “presumption of reliance” in consumer fraud class actions· Caldwell v. [read post]
22 Feb 2008, 1:30 pm
In a crushing blow to consumers, on Thursday, February 21st, the United States Supreme Court again sided with big pharmaceutical medical device makers. [read post]
6 Mar 2014, 12:41 pm
Thus FDA-approved statements have been exempted from consumer protection/fraud liability:The pharmaceutical industry is highly regulated, both at the federal level and internationally. [read post]
28 Dec 2012, 1:57 pm
In re Schering Plough Corp. [read post]
12 Oct 2007, 7:03 am
Schering-Plough Corp., 2006 WL 2546494, at *2 (E.D. [read post]
